Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.2400 (-2.93%) ($13.1900 - $13.7400) on Wed. Aug. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.51% (three month average) | RSI | 56 | Latest Price | $13.2400(-2.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.255% in a week (0% probabilities). VIXM(-32%) VXX(-27%) UNG(-11%) UUP(-8%) TLT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.255% (StdDev 4.51%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
5 Day Moving Average | $13.15(0.68%) | 10 Day Moving Average | $12.81(3.36%) | 20 Day Moving Average | $12.73(4.01%) | To recent high | -14.6% | To recent low | 48.1% | Market Cap | $984m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |